Lucid Diagnostics Inc (LUCD)vsMedtronic PLC (MDT)
LUCD
Lucid Diagnostics Inc
$0.54
-10.38%
HEALTHCARE · Cap: $121.83M
MDT
Medtronic PLC
$93.01
+1.31%
HEALTHCARE · Cap: $111.40B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 689377% more annual revenue ($37.54B vs $5.45M). MDT leads profitability with a 13.9% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 68/100 (B-).
LUCD
Avoid24
out of 100
Grade: F
MDT
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LUCD.
Margin of Safety
+9.3%
Fair Value
$94.25
Current Price
$93.01
$1.24 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 26.7% year-over-year
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 40.7% YoY
Generating 1.3B in free cash flow
Areas to Watch
Trading at 9.1x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Expensive relative to growth rate
Grey zone — moderate risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LUCD
The strongest argument for LUCD centers on Revenue Growth. Revenue growth of 26.7% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.
Bear Case : LUCD
The primary concerns for LUCD are Price/Book, EPS Growth, Market Cap. Debt-to-equity of 2.28 is elevated, increasing financial risk.
Bear Case : MDT
The primary concerns for MDT are PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
LUCD profiles as a growth stock while MDT is a value play — different risk/reward profiles.
LUCD carries more volatility with a beta of 1.12 — expect wider price swings.
LUCD is growing revenue faster at 26.7% — sustainability is the question.
MDT generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (68/100 vs 24/100) and 13.7% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lucid Diagnostics Inc
HEALTHCARE · MEDICAL DEVICES · USA
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?